American Journal of Epidemiology Vol. 144, No. 11: 1041-1047
Copyright © 1996 by The Johns Hopkins University School of Hygiene and Public Health
other |
Family History and Prostate Cancer Risk
Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine Brookline, MA
Reprint request to Dr. Samuel M. Lesko, Slone Epidemiology Unit, 1371 Baacon Street, Brookline, MA 02146.
The authors examined the relation between family history of prostate cancer and the risk of this cancer in a population-based case-control study conducted in Massachusetts between December 1992 and October 1994. Cases were all incident cases of prostate cancer in men younger than 70 years (n = 563); controls were men with no history of the disease matched to the cases on age and town of residence (n = 703). Prostate cancer risk was increased among men who reported a history of this cancer in either their fathers or brothers (odds ratio (OR) = 2.3, 95% confidence interval (Cl) 1.7–3.3). Risk varied with the number of relatives affected and their relationship to the case. For a history of prostate cancer in one relative, the OR was 2.2 (95% Cl 1.5–3.2); if two or more relatives were affected, it was 3.9 (95% Cl 1.7–5.2). For prostate cancer in the father, the OR was 1.9 (95% Cl 1.2–3.0); for prostate cancer in a brother, it was 3.0 (95% Cl 1.8–4.9). Risk was inversely related to the subject's age and to age at diagnosis of prostate cancer in his affected relative. Among probands younger than 60 years, the OR was 5.3 (95% Cl 2.5–12); for those 60–64 years of age, the OR was 2.7 (95% Cl 1.3–5.5); and for those 65 years of age and older, the OR was 1.6 (95% Cl 1.0–2.5). For prostate cancer diagnosed in a relative before age 65, the OR was 4.1 (95% Cl 2.3–7.3); for detection of the disease after age 74, the OR was 0.76 (95% Cl 0.38–1.5). The association was present both among men with local and advanced stage disease and among men whose prostate cancer was detected either by screening or because of symptoms. These data provide evidence that after controlling for diet and other potential confounders, familial factors are significantly associated with the risk of prostate cancer. Am J Epidemiol 1996;144:1041-7.
epidemiologic factors; family; men; prostatic neoplasms; risk factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Zabaleta, L. J. Su, H.-Y. Lin, R. A. Sierra, M. C. Hall, A. O. Sartor, P. E. Clark, J. J. Hu, and A. C. Ochoa Cytokine genetic polymorphisms and prostate cancer aggressiveness Carcinogenesis, August 1, 2009; 30(8): 1358 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zabaleta, H.-Y. Lin, R. A. Sierra, M.C. Hall, P. E. Clark, O. A. Sartor, J. J. Hu, and A. C. Ochoa Interactions of cytokine gene polymorphisms in prostate cancer risk Carcinogenesis, March 1, 2008; 29(3): 573 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagata, T. Sonoda, M. Mori, N. Miyanaga, K. Okumura, K. Goto, S. Naito, K. Fujimoto, Y. Hirao, A. Takahashi, et al. Dietary Isoflavones May Protect against Prostate Cancer in Japanese Men J. Nutr., August 1, 2007; 137(8): 1974 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Bloom, S. L. Stewart, I. Oakley-Girvans, P. J. Banks, and S. Chang Family History, Perceived Risk, and Prostate Cancer Screening among African American Men. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Murff, D. R. Spigel, and S. Syngal Does This Patient Have a Family History of Cancer?: An Evidence-Based Analysis of the Accuracy of Family Cancer History JAMA, September 22, 2004; 292(12): 1480 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schaid The complex genetic epidemiology of prostate cancer Hum. Mol. Genet., April 1, 2004; 13(90001): R103 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Stanford, L. P. Sabacan, E. A. Noonan, L. Iwasaki, J. Shu, Z. Feng, and E. A. Ostrander Association of HPC2/ELAC2 Polymorphisms with Risk of Prostate Cancer in a Population-based Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Makinen, T. L.J. Tammela, U.-H. Stenman, L. Maattanen, S. Rannikko, J. Aro, H. Juusela, M. Hakama, and A. Auvinen Family History and Prostate Cancer Screening With Prostate-Specific Antigen J. Clin. Oncol., June 1, 2002; 20(11): 2658 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lichtenstein, N. V. Holm, P. K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki Environmental and Heritable Factors in the Causation of Cancer -- Analyses of Cohorts of Twins from Sweden, Denmark, and Finland N. Engl. J. Med., July 13, 2000; 343(2): 78 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Jarvik, J. L. Stanford, E. L. Goode, R. McIndoe, S. Kolb, M. Gibbs, L. Hood, and E. A. Ostrander Confirmation of Prostate Cancer Susceptibility Genes Using High-Risk Families J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 81 - 87. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. P. Matikainen, J. Schleutker, P. Morsky, O.-P. Kallioniemi, and T. L. J. Tammela Detection of Subclinical Cancers by Prostate-specific Antigen Screening in Asymptomatic Men from High-Risk Prostate Cancer Families Clin. Cancer Res., June 1, 1999; 5(6): 1275 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cerhan, A. S. Parker, S. D. Putnam, B. C-H. Chiu, C. F. Lynch, M. B. Cohen, J. C. Torner, and K. P. Cantor Family History and Prostate Cancer Risk in a Population-Based Cohort of Iowa Men Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 53 - 60. [Abstract] [Full Text]
|
|